Gender
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (Sleep Heart Health Study Visit Two (SHHS2)) vs Sleep Heart Health Study (SHHS) Visit Number
| Visit 1 | Interim Follow-up Visit | Visit 2 | CVD Outcomes | |
|---|---|---|---|---|
| Total | - | - | 4,080 | - |
| No | - | - | 3,470 | - |
| Yes | - | - | 150 | - |
| Unknown | - | - | 460 | - |
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (Sleep Heart Health Study Visit Two (SHHS2)) vs Gender of the participant
Visit 2
| Male | Female | Total | |
|---|---|---|---|
| Total | 1,861 | 2,219 | 4,080 |
| No | 1,568 | 1,902 | 3,470 |
| Yes | 93 | 57 | 150 |
| Unknown | 200 | 260 | 460 |
Oral Anticoagulants Including Warfarin, Coumadin, And Anisindione (Sleep Heart Health Study Visit Two (SHHS2)) vs Race of the participant
Visit 2
| White | Black | Other | Total | |
|---|---|---|---|---|
| Total | 3,587 | 256 | 237 | 4,080 |
| No | 3,028 | 232 | 210 | 3,470 |
| Yes | 134 | 10 | 6 | 150 |
| Unknown | 425 | 14 | 21 | 460 |